Form 4: Collegium Pharmaceutical EVP Shirley Kuhlmann Reports Stock Transactions

EVP and General Counsel of Collegium Pharmaceutical, Shirley Kuhlmann, reports acquisition and disposal of company stock, including vesting of restricted stock units and performance share units, as well as shares withheld for taxes.

Summary

• On February 10, 2025, Shirley Kuhlmann, EVP and General Counsel of Collegium Pharmaceutical, reported transactions involving the company's common stock.
• Kuhlmann acquired 40,965 shares through the grant of restricted stock units (RSUs) and 29,030 shares through the vesting of performance share units (PSUs).
• The RSUs vest over three years, starting February 10, 2026.
• The vesting of PSUs was determined by the Compensation Committee of the Board of Directors.
• A total of 9,826 and 25,149 shares were withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs and RSUs respectively.
• Following these transactions, Kuhlmann beneficially owns 154,204 shares of Collegium Pharmaceutical.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine stock transactions related to executive compensation. The vesting of PSUs suggests positive performance, but the tax withholdings are a neutral event.

Positives

• The vesting of RSUs and PSUs indicates that Kuhlmann is incentivized to contribute to the company's success.
• The vesting of PSUs suggests that performance-vesting criteria were met, reflecting positively on the company's performance.

Negatives

• The withholding of shares for taxes reduced the number of shares directly received by Kuhlmann.

Future Outlook

The RSUs will continue to vest in equal annual installments over the two-year period following February 10, 2026, subject to continued service.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the compensation structure for Collegium Pharmaceutical executives.

Comparison to Industry Standards

• Stock-based compensation, including RSUs and PSUs, is a common practice among publicly traded companies to align executive interests with shareholder value.
• The vesting schedules and performance criteria associated with these grants are typically benchmarked against industry peers to ensure competitiveness and effectiveness.

Stakeholder Impact

• Shareholders may view the vesting of PSUs as a positive sign of company performance.
• Employees may be impacted by the company's overall performance, which influences the vesting of performance-based compensation.

Key Dates